Development and validation of an AI-based PD-L1 scoring algorithm in NSCLC samples

被引：0
|
作者：
Rodrigues, Daniela
Neppl, Christina
Dorward, David
Losmanova, Tereza
Wyatt, Rebecca
Pattle, Samuel
Oberson, Raphael
Reinhard, Stefan
Waldburger, Therese
Zlobec, Inti
Caie, Peter
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3294
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Development of a proximity-based immunoassay to measure the PD1:PD-L1 complex in fixed samples
    Wallweber, Gerald
    Ravanera, Roy
    Chenna, Ahmed
    Stathas, David
    Huang, Weidong
    Winslow, John
    Petropoulos, Christos
    CANCER RESEARCH, 2016, 76
  • [22] Predicting EGFR and PD-L1 Status in NSCLC Patients Using Multitask AI System Based on CT Images
    Wang, Chengdi
    Ma, Jiechao
    Shao, Jun
    Zhang, Shu
    Liu, Zhongnan
    Yu, Yizhou
    Li, Weimin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] PD-L1 expression in bladder cancer: Which scoring algorithm in what tissue?
    Schulz, Gerald Bastian
    Todorova, Rumyana
    Braunschweig, Till
    Rodler, Severin
    Volz, Yannic
    Eismann, Lennert
    Pfitzinger, Paulo
    Jokisch, Friedrich
    Buchner, Alexander
    Stief, Christian
    Mayr, Doris
    Casuscelli, Jozefina
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 734.e1 - 734.e10
  • [24] Optimized PD-L1 scoring of gastric cancer
    Birgid Schoemig-Markiefka
    Jana Eschbach
    Andreas H. Scheel
    Aylin Pamuk
    Josef Rueschoff
    Thomas Zander
    Reinhard Buettner
    Wolfgang Schroeder
    Christiane J. Bruns
    Heike Loeser
    Hakan Alakus
    Alexander Quaas
    Gastric Cancer, 2021, 24 : 1115 - 1122
  • [25] Optimized PD-L1 scoring of gastric cancer
    Schoemig-Markiefka, Birgid
    Eschbach, Jana
    Scheel, Andreas H.
    Pamuk, Aylin
    Rueschoff, Josef
    Zander, Thomas
    Buettner, Reinhard
    Schroeder, Wolfgang
    Bruns, Christiane J.
    Loeser, Heike
    Alakus, Hakan
    Quaas, Alexander
    GASTRIC CANCER, 2021, 24 (05) : 1115 - 1122
  • [26] Macrophages are important source of PD-L1 and PD-L1 expressing in macrophages affect the prognosis of NSCLC patients with tumor PD-L1 negative
    Liu, Y.
    Cao, L.
    Che, X.
    Qiu, X.
    Li, Z.
    Yang, B.
    Wang, S.
    Qu, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 531 - 532
  • [27] PD-L1 expression in NSCLC and biopsy size
    Kern, I.
    Kovacevic, M.
    Janzic, U.
    Cufer, T.
    VIRCHOWS ARCHIV, 2016, 469 : S127 - S127
  • [28] Radiotherapy and PD-L1 inhibition in metastatic NSCLC
    De Ruysscher, Dirk
    LANCET ONCOLOGY, 2017, 18 (07): : 840 - 842
  • [29] PD-L1 Assessment in Cytology Samples
    Lerner, A.
    Yarmus, L.
    Illei, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2114 - S2114
  • [30] PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC
    Lau, Sally C. M.
    Rabindranath, Madhumitha
    Weiss, Jessica
    Li, Janice J. N.
    Fung, Andrea S.
    Mullen, Dorinda
    Alshamlan, Najd
    Ruff, Heather M.
    Tong, Leung Chu B.
    Pal, Prodipto
    Cabanero, Michael R.
    Hsu, Ying-Han R.
    Sacher, Adrian G.
    Shepherd, Frances A.
    Liu, Geoffrey
    Bradbury, Penelope A.
    Yasufuku, Kazuhiro
    Czarnecka-Kujawa, Katarzyna
    Ko, Hyang Mi
    Tsao, Ming-Sound
    Leighl, Natasha B.
    Schwock, Joerg
    LUNG CANCER, 2022, 171 : 42 - 46
12345